Literature DB >> 25373528

Low dietary intake of magnesium is associated with increased externalising behaviours in adolescents.

Lucinda J Black1, Karina L Allen1, Peter Jacoby1, Gina S Trapp1, Caroline M Gallagher1, Susan M Byrne2, Wendy H Oddy1.   

Abstract

OBJECTIVE: Adequate Zn and Mg intakes may be beneficial for the prevention and treatment of mental health problems, such as depression, anxiety and attention-deficit hyperactivity disorder. We aimed to investigate the prospective association between dietary intakes of Zn and Mg and internalising and externalising behaviour problems in a population-based cohort of adolescents.
DESIGN: Prospective analysis (general linear mixed models) of dietary intakes of Zn and Mg assessed using a validated FFQ and mental health symptoms assessed using the Youth Self-Report (YSR), adjusting for sex, physical activity, family income, supplement status, dietary misreporting, BMI, family functioning and energy intake.
SETTING: Western Australian Pregnancy Cohort (Raine) Study.
SUBJECTS: Adolescents (n 684) at the 14- and 17-year follow-ups.
RESULTS: Higher dietary intake of Mg (per SD increase) was significantly associated with reduced externalising behaviours (β = -1.45; 95% CI -2.40, -0.50; P = 0.003). There was a trend towards reduced externalising behaviours with higher Zn intake (per SD increase; β = -0.73; 95% CI -1.57, 0.10; P = 0.085).
CONCLUSIONS: The study shows an association between higher dietary Mg intake and reduced externalising behaviour problems in adolescents. We observed a similar trend, although not statistically significant, for Zn intake. Randomised controlled trials are necessary to determine any benefit of micronutrient supplementation in the prevention and treatment of mental health problems in adolescents.

Entities:  

Keywords:  Dietary intake; Magnesium; Mental health; Raine Study

Mesh:

Substances:

Year:  2014        PMID: 25373528     DOI: 10.1017/S1368980014002432

Source DB:  PubMed          Journal:  Public Health Nutr        ISSN: 1368-9800            Impact factor:   4.022


  7 in total

1.  Complementary and alternative medicine in ADHD treatment: more soundly designed clinical trials needed.

Authors:  Rong-Wang Yang; Rong Li
Journal:  World J Pediatr       Date:  2019-01-28       Impact factor: 2.764

2.  Gene-based analyses reveal novel genetic overlap and allelic heterogeneity across five major psychiatric disorders.

Authors:  Huiying Zhao; Dale R Nyholt
Journal:  Hum Genet       Date:  2016-12-29       Impact factor: 4.132

3.  Assessing the Evidence of Micronutrients on Depression among Children and Adolescents: An Evidence Gap Map.

Authors:  Susan C Campisi; Clare Zasowski; Shailja Shah; Ashka Shah; Glyneva Bradley-Ridout; Daphne J Korczak; Peter Szatmari
Journal:  Adv Nutr       Date:  2020-07-01       Impact factor: 8.701

4.  Lower dietary intake of magnesium is associated with more callous-unemotional traits in children.

Authors:  Jill Portnoy; Samantha H McGouldrick; Adrian Raine; Babette S Zemel; Katherine L Tucker; Jianghong Liu
Journal:  Nutr Neurosci       Date:  2021-09-03       Impact factor: 4.994

Review 5.  Change in diet in the period from adolescence to early adulthood: a systematic scoping review of longitudinal studies.

Authors:  Eleanor M Winpenny; Tarra L Penney; Kirsten Corder; Martin White; Esther M F van Sluijs
Journal:  Int J Behav Nutr Phys Act       Date:  2017-05-04       Impact factor: 6.457

6.  The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial.

Authors:  Mahsima Jaripur; Hatav Ghasemi-Tehrani; Gholamreza Askari; Mahsa Gholizadeh-Moghaddam; Cain C T Clark; Mohammad Hossein Rouhani
Journal:  Reprod Biol Endocrinol       Date:  2022-08-02       Impact factor: 4.982

Review 7.  Magnesium, Iron, Zinc, Copper and Selenium Status in Attention-Deficit/Hyperactivity Disorder (ADHD).

Authors:  Harry Robberecht; Annelies A J Verlaet; Annelies Breynaert; Tess De Bruyne; Nina Hermans
Journal:  Molecules       Date:  2020-09-27       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.